博尔特佐米布是否会影响移植前的脱敏治疗,或对高度敏感的患者的心脏移植后的结果有好处?
Manvir Dhillon1, Jon A Kobashigawa1, Michelle Kittleson1
1Cedars-Sinai Heart Institute, Los Angeles, California, USA.
Clinical transplantation
|October 14, 2023
概括
与血相结合的伯特佐米布在高度敏感的心脏移植候选人中没有显著降低抗体. 然而,这种脱敏感化策略可能会改善供体心脏的兼容性,并导致可接受的移植后结果.
科学领域:
- 免疫学 免疫学 免疫学
- 心脏病学 心脏病学
- 移植 移植 移植 移植
背景情况:
- 高度敏感的患者在心脏移植中面临挑战,原因是对捐赠者抗原的抗体.
- 作为一种蛋白酶体抑制剂的博特佐米布 (Bortezomib) 在有限的心脏移植病例中显示出作为一种脱敏化策略的潜力.
- 这项研究评估了博特佐米布与血相结合的疗效,用于高度敏感的心脏移植接受者的脱敏化.
结论:
- 在高度敏感的患者中,与血相结合的伯特佐米布在心脏移植前并没有显著降低循环抗体.
- 尽管抗体水平不高,但治疗可能会增加找到兼容的供体心脏的可能性.
- 移植后的结果,包括1年生存率,与非敏感患者相比,尽管排斥率更高.
关键词:
这种HLA抗体是HLA抗体.博尔特佐米布 (Bortezomib) 是一种药物.脱敏感化 脱敏感化心脏移植心脏移植的心脏移植血相结合 (plasmapheresis) 是一个过程.敏感的 敏感的更多相关视频
11:55Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
Published on: March 14, 2011
14.6K
18:48In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
Published on: August 12, 2017
14.4K
相关概念视频
Tissue Transplantation
380
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
380
Kidney Transplant I: Introduction
14
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
14
Bone Marrow Sampling and Transplants
342
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
342
Kidney Transplant II: Surgical Procedure
21
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
21
